UK Markets open in 7 hrs 26 mins

Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript

·30-min read
Silence Therapeutics plc (SLN) Q2 2021 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Joining me today on the call are Mark Rothera, our president and CEO, who will provide an update on the business; Dr. Giles Campion, our head of R&D and chief medical officer, who will provide an update on our clinical programs; and Craig Tooman, our chief financial officer, who will review our financials before opening the call to your questions. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual report on file with the SEC.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting